Revolution Medicines, Inc. (rvmd)
RVMD Estimates
Public analyst price targets and consensus snapshot for Revolution Medicines, Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $190.74 |
| Analyst mean target | $253.30 |
| Analyst high target | $320.00 |
| Analyst low target | $179.00 |
| Upside vs mean target | 32.8% |
| Consensus recommendation | Strong Buy |
| Number of analysts | 21 |
| Forward P/E | -31.71 |
Start Free — open RVMD in Vest Terminal
Access live data, filings, ownership, and analysis for Revolution Medicines, Inc..
Revolution Medicines, Inc. FAQ
What does Revolution Medicines, Inc. (RVMD) do?
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination wit…
What is RVMD's P/E ratio?
Revolution Medicines, Inc. has a trailing P/E of N/A× based on publicly available market data.
Does RVMD pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is RVMD in?
Revolution Medicines, Inc. is classified in Healthcare (Biotechnology) on NMS.
What is RVMD's market capitalization?
Approximate market cap: $40.88B.
What are the main risks for RVMD?
Key risks include above-average volatility (beta 1.41), among factors on this page.
What are the strengths of RVMD?
Potential positives include moderate leverage (debt/equity 45.68), large cap scale ($40.88b) may provide distribution and funding advantages.
Where can I get analyst estimates for RVMD?
Public analyst price targets and consensus for Revolution Medicines, Inc. are on the free /stocks/rvmd/estimates page. Deeper estimate history and models are available in Vest Terminal.